top of page
IN THE NEWS
iXpressGenes develops new high performing DNA polymerase for COVID-19 and other pathogen testing
HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY
Scientists at iXpressGenes, on the campus of HudsonAlpha Institute for Biotechnology have engineered a new reagent, critical to pathogen detection testing.
iXpressGenes awarded a $1M DoD contract to develop novel antibiotics from extremophilic microbiomes
HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY
iXpressGenes (iXG) has been awarded a $1,000,000 Phase II Department of Defense (DoD) Small Business Innovation contract to develop extremophile-derived antibiotics to protect soldiers from biowarfare agents and “superbugs.”
bottom of page